Search Result
List
1Cases
2018-02-14 - 2022-12-31
Phase I/II
Completed
A Phase I/II study to determine the maximum tolerated dose (MTD) and to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of antroquinonol in combination with nab-paclitaxel and gemcitabine in first line metastatic pancreatic cancer.
-
Condition/Disease
Pancreatic Neoplasm
-
Test Drug
Hocena
Participate Sites
2Sites
Recruiting2Sites
李重賓
Taipei Veterans General Hospital
Division of Hematology & Oncology
沈延盛
National Taiwan University Hospital
Division of General Surgery
